Nanotechnology has emerged as a favorable alternative for the treatment and identification
of various neurodegenerative conditions. Nanomedicine is a division of a newly developing …

Alzheimer's disease (AD) is one of the neurodegenerative diseases that leads to the
deposition of amyloid plaques in the neuropil as well as outside the cells in the brain leading …

Nanotechnology is a great choice for medical research, and the green synthesis approach is
a novel and better way to synthesize nanoparticles. Biological sources are cost-effective …

Alzheimer's disease (AD) is a neurodegenerative disorder primarily characterized by β-
amyloid plaque, intraneuronal tangles, significant neuronal loss and cognitive deficit …

Alzheimer's disease (AD) is one of the most devastating neurological disorders causing
memory loss and impairment of cognitive functions. It is distinguished by the presence of …

Alzheimer's disease affects millions of people worldwide and this figure is continuously
increasing. Currently, there is no resolutive cure for this disorder, but a valid contribution …

A century of research has passed since the discovery and definition of Alzheimer's disease
(AD), the primary common dementing disorder worldwide. However, AD lacks definite …

The buildup of beta-amyloid plaques in the brain results in Alzheimer's disease (AD), a
neurodegenerative condition. A permanent treatment for AD is not yet available. Only a …

Alzheimer's disease (AD) is the most common cause of dementia and afflicts an estimated
16 million people worldwide. Clinical diagnosis can be made with only 65–90% accuracy …

Alzheimer's disease is a neurodegenerative disorder that ultimately results from the
accumulation of beta-amyloid plaques in the brain. The Alzheimer's disease cannot be …